Isomorphic Labs, Alphabet's London-based drug discovery company, announced a $5 billion funding round on Tuesday. Investment firms Greenoaks and Sequoia Capital led the round, which comes six months after a smaller raise in May. The company says the money will move its first drug programs into human trials.